Table 2 Site of biopsy of metastatic lesions and number and type of treatments for advance setting
Patients characteristics | Metastatic cases (n = 18) | |
|---|---|---|
n | (%) | |
Site of biopsy | ||
lymph node | 4 | (22.2) |
liver | 4 | (22.2) |
bone | 3 | (16.6) |
skin | 1 | (5.6) |
pleura | 2 | (11.1) |
ovary | 2 | (11.1) |
lung | 1 | (5.6) |
breast | 1 | (5.6) |
Max/last line of palliative CT | ||
No CT | 11 | (61.1) |
III line | 2 | (11.1) |
≥ IV line | 5 | (27.8) |
Max/last line of palliative HT | ||
No HT | 7 | (38.9) |
I line | 6 (2a) | (33.3) |
II line | 3 (1a) | (16.7) |
III line | 2 (1a) | (11.1) |
Max/last Line of treatment for advanced disease | ||
I | 6 (3a) | (33.3) |
II | 3 (1a) | (16.7) |
III | 3 (2a) | (16.7) |
IV-IX | 6 (2a) | (33.3) |